Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.48 |
| ▸ | USP2 | O75604 | 1/20 | 0.46 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | PDE4A | P27815 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.34 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3851276 | 1.00 | LMNA (0.48) | LMNAL3MBTL1USP2SLCO1B1TDP1 | |
| SCHEMBL15754347 | 1.00 | LMNA (0.48) | LMNAL3MBTL1USP2SLCO1B1TDP1 | |
| SCHEMBL26091297 | 1.00 | LMNA (0.48) | LMNAL3MBTL1USP2SLCO1B1TDP1 | |
| Hydrochloric Acid SCHEMBL28610464 | 0.98 | LMNA (0.46) | LMNAL3MBTL1USP2SLCO1B1TDP1 | |
| SCHEMBL7510580 | 0.95 | LMNA (0.55) | LMNAL3MBTL1USP2SLCO1B1TDP1 | |
| SCHEMBL2480041 | 0.84 | USP2 (0.39) | LMNAL3MBTL1USP2SLCO1B1TDP1 | |
| SCHEMBL26092953 | 0.84 | USP2 (0.39) | LMNAL3MBTL1USP2SLCO1B1TDP1 | |
| Xylitol SCHEMBL4750185 | 0.84 | LMNA (0.59) | LMNAL3MBTL1USP2SLCO1B1TDP1 | |
| SCHEMBL29620322 | 0.82 | LMNA (0.50) | LMNAL3MBTL1USP2SLCO1B1TDP1 | |
| SCHEMBL21014430 | 0.82 | LMNA (0.50) | LMNAL3MBTL1USP2SLCO1B1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 100 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110643032-B | Eight-arm polyethylene glycol, preparation method, functionalized derivative and modified biologically-relevant substance | 厦门赛诺邦格生物科技股份有限公司 | 2022-01-28 | — | — | CN | claimed |
| CN-111484565-A | Sweet wormwood polysaccharide, preparation method thereof and application thereof in preparation of anticomplement medicines | 复旦大学 | 2020-08-04 | — | — | CN | claimed |
| CN-110643032-A | Eight-arm polyethylene glycol, preparation method, functionalized derivative and modified biologically-relevant substance | 厦门赛诺邦格生物科技股份有限公司 | 2020-01-03 | — | — | CN | claimed |
| CN-106967213-B | Eight-arm polyethylene glycol, preparation method, functionalized derivative and modified biologically-relevant substance | 厦门赛诺邦格生物科技股份有限公司 | 2019-11-05 | — | — | CN | claimed |
| CN-106967213-A | Eight-arm polyethylene glycol, preparation method, functionalized derivative and modified biologically-relevant substance | 厦门赛诺邦格生物科技股份有限公司 | 2017-07-21 | — | — | CN | claimed |
| CN-102166189-A | Target and fluorescence dual-functional slightly-soluble antitumor medicament nano structural lipid carrier | UNIV CHINA PHARMA | 2011-08-31 | — | — | CN | claimed |
| US-12605431-B2 | Composition for treating or preventing myopathy, obesity or diabetes | NB SCIENCE CO., LTD. (KR) | 2026-04-21 | — | — | US | disclosed |
| CN-118401655-A | Sialyltransferase for producing sialylated oligosaccharides | 因比奥斯公司 | 2024-07-26 | — | — | CN | disclosed |
| WO-2024151612-A1 | COMPOSITIONS FOR INDUCING IMMUNE RESPONSES | DERMATA THERAPEUTICS, INC. (US) | 2024-07-18 | — | — | WO | disclosed |
| CN-117957316-A | Fucosyltransferase for converting lactose-N-disaccharide | 因比奥斯公司 | 2024-04-30 | — | — | CN | disclosed |
| US-20240099962-A1 | COMPOSITIONS FOR THE TREATMENT OF SKIN CONDITIONS | DERMATA THERAPEUTICS, INC. | 2024-03-28 | — | — | US | disclosed |
| US-20240058428-A1 | COMPOSITION FOR TREATING OR PREVENTING MYOPATHY, OBESITY OR DIABETES | NB SCIENCE CO., LTD. (KR) | 2024-02-22 | — | — | US | disclosed |
| CN-117157396-A | Cell production of sialylated di-and/or oligosaccharides | 因比奥斯公司 | 2023-12-01 | — | — | CN | disclosed |
| EP-0829104-A1 | HIGH ENERGY DENSITY VANADIUM ELECTROLYTE SOLUTIONS, METHODS OF PREPARATION THEREOF AND ALL-VANADIUM REDOX CELLS AND BATTERIES CONTAINING HIGH ENERGY VANADIUM ELECTROLYTE SOLUTIONS | UNISEARCH LIMITED (AU) | 1998-03-18 | — | — | EP | disclosed |
| WO-1996035239-A1 | HIGH ENERGY DENSITY VANADIUM ELECTROLYTE SOLUTIONS, METHODS OF PREPARATION THEREOF AND ALL-VANADIUM REDOX CELLS AND BATTERIES CONTAINING HIGH ENERGY VANADIUM ELECTROLYTE SOLUTIONS | UNISEARCH LIMITED (AU) | 1996-11-07 | — | — | WO | disclosed |
| US-5451689-A | Method of preparing epoxide | JAPAN TOBACCO, INC. (JP) | 1995-09-19 | — | — | US | disclosed |
| EP-0604656-A1 | PROCESS FOR PRODUCING EPOXIDE | Japan Tobacco Inc. (JP) | 1994-07-06 | — | — | EP | disclosed |
| US-4868155-A | IMMUNE SYSTEM STIMULANTS | MERCK & CO., INC. (US) | 1989-09-19 | — | — | US | disclosed |
| US-4184917-A | VIRICIDES, BIOSYNTHESIS WITH GALACTOSIDASE | SANDOZ LTD. (CH) | 1980-01-22 | — | — | US | disclosed |
| US-4061538-A | GALACTOSE OXIDASE | SANDOZ LTD. (CH) | 1977-12-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12605431-B2 | Composition for treating or preventing myopathy, obesity or diabetes | MTPN, ADAMTS1, ADAMTS13 | LMNA 588/4885L3MBTL1 111/4885USP2 2399/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.